바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.64 No.1
Citation Share

The Utility of MAGE Gene Detection in Bronchial Washing Fluid for Patients with Peripheral NSCLC

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2008, v.64 no.1, pp.15-21











& (2008). The Utility of MAGE Gene Detection in Bronchial Washing Fluid for Patients with Peripheral NSCLC. Tuberculosis & Respiratory Diseases, 64(1), 15-21.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: The melanoma antigen-encoding (MAGE) genes are known to be expressed in various cancer cells, including non-small cell lung cancer (NSCLC), and are silent in all normal tissues except for the testis. In patients with peripheral NSCLC, bronchial washing fluid can be used to detect the MAGE genes, suggesting a diagnosis of lung cancer. In order to evaluate the diagnostic utility of the MAGE test in patients with peripheral NSCLC, bronchial washing fluid was investigated in patients with peripheral pulmonary nodules, which were invisible as detected by bronchoscopy.Methods: Bronchial washing fluid from 37 patients was used for cytological examinations and MAGE gene detection, using RT-nested-PCR of common A1-A6 mRNA. Results were compared to a final diagnosis of patients as confirmed by pathology.Results: Among the 37 subjects, NSCLC was diagnosed in 21 patients, and benign pulmonary diseases were diagnosed in 16 patients. MAGE mRNA was detected in 10 of 21 (47.6%) NSCLC patients, while conventional cytology examinations were positive for MAGE expression in 2 of 21 (9.5%) cases. MAGE expression was observed in 4 of 16 (25%) benign pulmonary disease patients.Conclusion: The MAGE test of bronchial washing fluid can be used as a sensitive predictor of peripheral NSCLC patients.

keywords
Melanoma antigen gene (MAGE), Lung neoplasm, Coin lesion

Reference

1.

Korea Central Cancer Registry Center. Annual report of the Korea central cancer registry 2002. Seoul: Ministry of Health and Welfare; 2007.

2.

Korea National Statistical Office. Annual report on the cause of death statistics 2002. Seoul: Korea National Statistical Office; 2003.

3.

Ito S, Kawano Y, Katakura H, Takenaka K, Adachi M, Sasaki M, et al. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer. Lung Cancer 2006;51:79-88.

4.

Tanaka F, Yanagihara K, Otake Y, Miyahara R, Kawano Y, Nakagawa T, et al. Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend. Eur J Cardiothorac Surg 2000;18:147-55.

5.

Scientific Committee of Korean Academy of Tuberculosis and Repiratory Disease. The national survey of lung cancer in Korea. Tuberc and Respir Dis 1999; 46:455-65.

6.

Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker S Jr, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004;22: 330-53.

7.

Fong KM, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med 2002;23:83-101.

8.

van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.

9.

Jungbluth AA, Busam KJ, Kolb D, Iversen K, Coplan K, Chen YT, et al. Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer 2000;85:460-5.

10.

Kim KC, Seo CG, Park SH, Choi WI, Han SB, Jeon YJ, et al. Diagnostic utility of MAGE expression in exudative pleural effusion. Tuberc Respir Dis 2004;56:159-68.

11.

Zendman AJ, Ruiter DJ, Van Muijen GN. Cancer/testis-associated genes: identification, expression profile, and putative function. J Cell Physiol 2003;194:272-88.

12.

Tsai JR, Chong IW, Chen YH, Yang MJ, Sheu CC, Chang HC, et al. Differential expression profile of MAGE family in non-small-cell lung cancer. Lung Cancer 2007;56:185-92.

13.

Jang SJ, Soria JC, Wang L, Hassan KA, Morice RC, Walsh GL, et al. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res 2001;61:7959-63.

14.

Gotoh K, Yatabe Y, Sugiura T, Takagi K, Ogawa M, Takahashi T, et al. Frequency of MAGE-3 gene expression in HLA-A2 positive patients with non-small cell lung cancer. Lung Cancer 1998;20:117-25.

15.

Shichijo S, Hayashi A, Takamori S, Tsunosue R, Hoshino T, Sakata M, et al. Detection of MAGE-4 protein in lung cancers. Int J Cancer 1995;64:158-65.

16.

Weynants P, Lethe B, Brasseur F, Marchand M, Boon T. Expression of mage genes by non-small-cell lung carcinomas. Int J Cancer 1994;56:826-9.

17.

Yoshimatsu T, Yoshino I, Ohgami A, Takenoyama M, Hanagiri T, Nomoto K, et al. Expression of the melanoma antigen-encoding gene in human lung cancer. J Surg Oncol 1998;67:126-9.

18.

Shin KC, Lee SJ, Kim KJ, Lee JW, Kim HJ, Chung JH, et al. The expression of melanoma antigen encoding gene in lung cancer. Korean J Med 2005;68:647-55.

19.

Jheon S, Hyun DS, Lee SC, Yoon GS, Jeon CH, Park JW, et al. Lung cancer detection by a RT-nested PCR using MAGE A1-6 common primers. Lung Cancer 2004;43:29-37.

20.

Klein JS, Zarka MA. Transthoracic needle biopsy. Radiol Clin North Am 2000;38:235-66.

21.

Li H, Boiselle PM, Shepard JO, Trotman-Dickenson B, McLoud TC. Diagnostic accuracy and safety of CT-guided percutaneous needle aspiration biopsy of the lung: comparison of small and large pulmonary nodules. AJR Am J Roentgenol 1996;167:105-9.

22.

Sanders C. Transthoracic needle aspiration. Clin Chest Med 1992;13:11-6.

23.

Lee HS, Kwon SY, Kim DK, Yoon HI, Lee SM, Lee JH, et al. Determinants of diagnostic bronchial washing in peripheral lung cancers. Int J Tuberc Lung Dis 2007;11:227-32.

24.

Goldstein RA, Rohatgi PK, Bergofsky EH, Block ER, Daniele RP, Dantzker DR, et al. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis 1990;142:481-6.

25.

Shure D. Fiberoptic bronchoscopy--diagnostic applications. Clin Chest Med 1987;8:1-13.

26.

Bilaceroglu S, Kumcuoglu Z, Alper H, Osma E, Cagirici U, Gunel O, et al. CT bronchus sign-guided bronchoscopic multiple diagnostic procedures in carcinomatous solitary pulmonary nodules and masses. Respiration 1998;65:49-55.

27.

Pirozynski M. Bronchoalveolar lavage in the diagnosis of peripheral, primary lung cancer. Chest 1992;102: 372-4.

28.

Mori K, Yanase N, Kaneko M, Ono R, Ikeda S. Diagnosis of peripheral lung cancer in cases of tumors 2 cm or less in size. Chest 1989;95:304-8.

29.

Wongsurakiat P, Wongbunnate S, Dejsomritrutai W, Charoenratanakul S, Tscheikuna J, Youngchaiyud P, et al. Diagnostic value of bronchoalveolar lavage and postbronchoscopic sputum cytology in peripheral lung cancer. Respirology 1998;3:131-7.

30.

Rivera MP, Mehta AC. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd ed). Chest 2007;132:131S-48S.

31.

De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci U S A 1996;93:7149-53.

32.

Fischer C, Gudat F, Stulz P, Noppen C, Schaefer C, Zajac P, et al. High expression of MAGE-3 protein in squamous-cell lung carcinoma. Int J Cancer 1997;71: 1119-21.

33.

Park JW, Kwon TK, Kim IH, Sohn SS, Kim YS, Kim CI, et al. A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol Methods 2002;266:79-86.

34.

Becker JC, Gillitzer R, Brocker EB. A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing. Int J Cancer 1994;58:346-8.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy